Botswana vs Burundi: Access to anti-retroviral drugs, male
Botswana
92.0%
in 2024
Burundi
90.0%
in 2024
Botswana rank
11th
Burundi rank
13th
Access to anti-retroviral drugs, male over time
- Botswana
- Burundi
How they compare
Botswana currently reports 92.0% against 90.0% in Burundi, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Burundi ahead.
Botswana ranks 11th and Burundi ranks 13th of 141 countries.
Botswana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Burundi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 6.8% | 12.3% | Botswana |
| 2010s | 64.8% | 45.6% | 19.2% | Botswana |
| 2020s | 87.8% | 85.4% | 2.4% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Botswana or Burundi?
- Botswana, at 92.0% against 90.0% in Burundi as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Botswana and Burundi?
- 2.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Burundi?
- 25 years are reported by both, from 2000 to 2024.
- How do Botswana and Burundi rank globally for access to anti-retroviral drugs, male?
- Botswana ranks 11th and Burundi ranks 13th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.